Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis

Introduction: Therapeutic targeting of inhibitors of the immune response has reached the clinical setting. Inhibitors of the novel receptor LAG3, which negatively regulates T-cell activation, are under investigation. Here we explore the presence and prognostic role of LAG3 in cancer. Methods: A syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Ramy R., Peinado, Paloma, Fuentes-Antrás, Jesús, Pérez-Segura, Pedro, Pandiella, Atanasio, Amir, Eitan, Ocaña, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803551/
https://www.ncbi.nlm.nih.gov/pubmed/31681578
http://dx.doi.org/10.3389/fonc.2019.01040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803551/
https://www.ncbi.nlm.nih.gov/pubmed/31681578
http://dx.doi.org/10.3389/fonc.2019.01040

Ejemplares similares